Investment Team
We are led by a cohesive team of three investment partners who bring diverse and complementary skillsets yet share a common background, working approach, and values. Our founders are two former McKinsey partners who have been investing together in healthcare venture capital since 2014.
We have a One Team culture and operating model.
Each partner shares responsibility for the success of every investment decision and portfolio company’s performance. Our values are collaboration, objectivity, entrepreneurship, and integrity.
Meet the Team
Paul Enever, PhD
Managing Director
Paul Enever co-founded Evidity Health Capital with Alejandro Sanchez in 2014. He has been working in the healthcare industry with a focus on med tech for nearly 20 years.
Before joining Evidity, Paul was a partner at McKinsey and Company. In his 12 years at McKinsey, he advised leading organizations across the biopharma, med tech, hospital, and healthcare services industries primarily in the U.S. and Europe as well as private equity firms specializing in healthcare. Paul’s work focused on growth strategy, sales and marketing, and licensing and acquisition. Previously, Paul worked within the R&D organization at Sandoz Pharmaceuticals and MIT’s Biotechnology Process Engineering Center.
He sits on the Boards of Directors of Cardiva Medical, Dune Medical Devices, Magnolia Medical Technologies, Poseidon Medical, and Standard Molecular.
Paul has a B.S. in chemical engineering from Rensselaer Polytechnic Institute and a Ph.D. in chemical engineering from the University of Minnesota where he studied wound healing and tissue engineering. For his work, Paul was the recipient of both a National Science Foundation Graduate Fellowship and the Whitaker Foundation Graduate Fellowship in Biomedical Engineering.
Domain expertise: Commercialization, technology assessment, market attractiveness
Paul Enever, PhD
Managing Director
Alejandro Sanchez
Managing Director
Alejandro Sanchez co-founded Evidity Health Capital with Paul Enever in 2014. He has nearly a decade of experience in PE/VC investing and has been advising boards and C-suite executives in the technology sector on commercialization, operations, and strategy for nearly 20 years.
Prior to joining Evidity, Alejandro was a co-founder and partner of Hermes Growth Partners, where he launched its Telecom, Media, and Technology Fund. He is a former partner at McKinsey and Company, where he worked in the telecom, media, and technology sectors across a diverse set of geographies, including the United States, Russia, Poland, Chile, Brazil, and Venezuela.
He serves on the Boards of Directors of bioTheranostics, Endogastric Solutions, and Poseidon Medical, and he is a board observer at Akili Interactive Labs.
Alejandro is a systems engineer with an MS in Engineering-Economic Systems from Stanford University.
Domain expertise: Leadership and talent, board effectiveness, exit readiness
Alejandro Sanchez
Managing Director
Adam Lessler, MD
Principal
Adam Lessler joined Evidity in 2015. He is a licensed physician with residency training in emergency medicine and over a decade of healthcare industry experience counseling Boards and senior leadership teams.
Prior to joining Evidity, Adam was an engagement manager at McKinsey & Company, where he served clients across the health care value chain, with a focus on provider growth and M&A/partnership strategy. Previously, Adam completed his internship in emergency medicine at the Hospital of the University of Pennsylvania and worked as an analyst in the Investment Banking Division at Goldman Sachs and as a research assistant in Harvard Medical School’s Department of Health Care Policy.
Adam serves on the Board of Directors of Standard Molecular, and he is a board observer at bioTheranostics, Magnolia Medical Technologies, and Sonde Health.
Adam has a B.A. in economics from Amherst College, an M.B.A. from the Wharton School of the University of Pennsylvania, and an M.D. from the Perelman School of Medicine at the University of Pennsylvania.
Domain expertise: Clinical evidence, reimbursement, hospital purchasing, health policy
Adam Lessler, MD
Principal